RVX-297, a BET bromodomain inhibitor, has therapeutic effects in preclinical models of acute inflammation and autoimmune disease
Jahagirdar, Ravi, Attwell, Sarah, Marusic, Suzana, Bendele, Alison, Shenoy, Narmada, McLure, Kevin G, Gilham, Dean, Norek, Karen, Hansen, Henrik C, Yu, Raymond, Tobin, Jennifer, Wagner, Gregory S, YouLanguage:
english
Journal:
Molecular Pharmacology
DOI:
10.1124/mol.117.110379
Date:
September, 2017
File:
PDF, 1.28 MB
english, 2017